Company
United StatesPublic company, NYSE: BMYBristol-Myers Squibb Company (NYSE: BMY), Wallingford, CT – FDA Inspections
Inspection records and compliance data for Bristol-Myers Squibb Company in Wallingford, Connecticut. 5 FDA inspections on record, last inspected September 17, 2015. Publicly traded as NYSE: BMY.
Company Profile
This profile covers Bristol-Myers Squibb Company based in Wallingford, Connecticut, United States.
FDA Inspection History
- FDA inspections
- 5
- OAI
- 0
- VAI
- 0
- NAI
- 5
- Form 483s
- 0
- Warning letters
- 0
First inspected September 14, 2010. Last inspected September 17, 2015.
FDA inspections (5)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| September 17, 2015 | NAI | Human Drugs · Bioresearch Monitoring | 945016 |
| November 25, 2013 | NAI | Human Drugs · Bioresearch Monitoring | 857394 |
| November 30, 2012 | NAI | Human Drugs · Bioresearch Monitoring | 812983 |
| December 2, 2010 | NAI | Human Drugs · Bioresearch Monitoring | 704230 |
| September 14, 2010 | NAI | Human Drugs · Bioresearch Monitoring | 682482 |
FDA documents
Form 483s (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Bristol-Myers Squibb Company
Stock ticker
BMY
Exchange
NYSE
Share price
$62.37
Market cap
$127.5B
Price as of
November 13, 2026
FEI Number
1283703
Address
5 Research Pkwy, Wallingford, Connecticut 06492, United States
Country
United States
ID: be7fcaee-1b54-4e0d-82a3-85d9c545b073